The hereditary cancer working group from SEOM recommends prostate cancer screening with annual serum PSA measurements in male BRCA2 carriers starting at age 40, while this screening approach can also be offered to BRCA1 carriers [42]. The gene discussed is BRCA1; the disease is prostate carcinoma.